Raising the bar for cancer therapy models

被引：38

作者：

Francia, Giulio ^{[1
]}

Kerbel, Robert S. ^{[1
]}

机构：

[1] Univ Toronto, Dept Med Biophys, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

来源：

NATURE BIOTECHNOLOGY | 2010年 / 28卷 / 06期

关键词：

CYCLOPHOSPHAMIDE; TUMOR;

D O I：

10.1038/nbt0610-561

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Can mouse cancer models predict the results of phase 3 clinical trials?

引用

页码：561 / 562

页数：2

共 13 条

[1] Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis [J].

Ebos, John M. L. ;

Lee, Christina R. ;

Cruz-Munoz, William ;

Bjarnason, Georg A. ;

Christensen, James G. ;

Kerbel, Robert S. .

CANCER CELL, 2009, 15 (03) :232-239

[2] Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2-Positive Human Breast Cancer Xenografts [J].

Francia, Giulio ;

Man, Shan ;

Lee, Chyan-Jang ;

Lee, Christina R. ;

Xu, Ping ;

Mossoba, Miriam E. ;

Emmenegger, Urban ;

Medin, Jeffrey A. ;

Kerbel, Robert S. .

CLINICAL CANCER RESEARCH, 2009, 15 (20) :6358-6366

[3] Maximizing mouse cancer models [J].

Frese, Kristopher K. ;

Tuveson, David A. .

NATURE REVIEWS CANCER, 2007, 7 (09) :645-658

[4]

INABA M, 1989, CANCER-AM CANCER SOC, V64, P1577, DOI 10.1002/1097-0142(19891015)64:8<1577::AID-CNCR2820640803>3.0.CO

[5]

2-I

[6]

Kerbel RS, 2003, CANCER BIOL THER, V2, P111

[7] Can the pharmaceutical industry reduce attrition rates? [J].

Kola, I ;

Landis, J .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) :711-715

[8] Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy [J].

Munoz, R ;

Man, S ;

Shaked, Y ;

Lee, CR ;

Wong, J ;

Francia, G ;

Kerbel, RS .

CANCER RESEARCH, 2006, 66 (07) :3386-3391

[9] Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development [J].

Peterson, JK ;

Houghton, PJ .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (06) :837-844

[10]

Rossi Antonio, 2009, Curr Drug Discov Technol, V6, P91

← 1 2 →